Global Travel Vaccines Market Size, Share, Strategies, Global Insights, Analysis and Forecasts, 2016 To 2020
Technavio Announces the Publication of its Research Report Global Travel Vaccines Market 2016-2020 Technavio recognizes the following companies as the key players in the global travel vaccines market: GlaxoSmithKline, Merck, Pfizer, and Sanofi. Other Prominent Vendors in the market are: Abbott, AstraZeneca, Bavarian Nordic, Baxter, Beijing Minhai Biotechnology, Bharat Biotech, Bharat Immunologicals and Biologicals, Bio-Med, Seqirus CSL, Crucell, CSL, Dynavax Technologies, Emergent BioSolutions, GlycoVaxyn, GreenSignal Bio Pharma, Hualan Biological Engineering, Imunoloski Zavod, Indian Immunologicals, Janssen Pharmaceuticals, JN International Medical, Kaketsuken, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, Novavax, Nuron Biotech, Panacea Biotec, Pfizer, Protein Sciences, Roche, SK Chemicals, Serum Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech, Takeda Pharmaceutical, Vacunas Finlay, Valeant Pharmaceuticals, Valneva, and Zydus Cadila. Browse full report with TOC @ https://marketreportscenter.com/reports/473579/global-travelvaccines-market-2016-2020 Commenting on the report, an analyst from Technavio’ s team said: “R&D is budding due to a strong need for new efficacious and better tolerated vaccines. The market presents huge growth potential for vendors because of the growing incidence of infectious disease. This requirement is creating a demand for novel vaccines where major players are focusing their R&D efforts and once launched, should become the major growth drivers. Increased investment in R&D by major pharmaceutical companies would fuel the growth of the global travel vaccines market.” According to the report, the growing demand for vaccines among international travelers is one of the major factors driving the market growth. Many international and national bodies have mandated that the immigrants should be vaccinated before traveling to disease-prone areas. Considering vaccines are largely perceived as a prevention mechanism against the spread of any infectious disease; it is making a specific requirement in international traveler's list. Further, the report states that vaccines are temperature sensitive in nature and hence, need to be kept under adequately controlled temperature throughout their supply chain. To avoid any loss of potency during its distribution, vaccines need to be kept in 'vaccine cold chain', which includes refrigerators or freezers. Inadequately stored vaccines lose their efficacy to protect against diseases and can lead to increased local reactions.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/473579 About Travel Vaccines As the world continues to move toward globalization, the international travels will keep increasing. This fuels the demand for travel vaccines as the prevalence of infectious diseases are specifically region prone, unlike that of other indications. As vaccines are largely used as a preventive measure against these known infectious diseases, the travelers are advised to follow the region-specific immunization plan. The market is growing because various government bodies have mandated the immunization of travelers visiting the infectious-prone areas with various types of vaccines. This, in turn, prevents the spread of infection and averts any chances of epidemic outbreaks. Technavioâ€™ s analysts forecast the global travel vaccines market to grow at a CAGR of 6.83% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global travel vaccines market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various vaccines administered to actively immunize meningococcal disease, Japanese encephalitis, rabies, typhoid, yellow fever, hepatitis B, and hepatitis A. The report also considers the revenues to be generated from the sales of vaccines that are expected to be launched into the market during the forecast period. The market is divided into the following segments based on geography: Americas APAC EMEA Technavio's report, Global Travel Vaccines Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To Get Discount On The Report @ https://marketreportscenter.com/request-discount/473579
Connect for more details: Sam Collins Market Reports Center 1-646-883-3044 (US) firstname.lastname@example.org
Published on Dec 2, 2016
According to the report, the growing demand for vaccines among international travelers is one of the major factors driving the market growth